Literature DB >> 17043923

Endoscopic subureteral injection treatment with calcium hydroxylapatite in primary vesicoureteral reflux.

Bilal Eryildirim1, Fatih Tarhan, Uğur Kuyumcuoğlu, Erkan Erbay, Gökhan Faydaci.   

Abstract

INTRODUCTION: In this study, we aimed to evaluate efficiency of subureteral injection of calcium hydroxylapatite treatment for primary vesicoureteral reflux (VUR).
MATERIALS AND METHODS: A total of 25 children (mean age 6.9 +/- 2.7 years) underwent subureteral injection of calcium hydroxylapatite for primary VUR. Reflux was present in 39 ureteral units that were unilateral in 11 cases and bilateral in 14 cases. According to "International Reflux Classification"; grade II in 12 (30.8%), grade III in 18 (46.2%) and grade IV in 9 (23.1%) ureteral units were found.
RESULTS: The refluxes were resolved in 23 (59.0%) ureteral units after a single injection and 5 ureteral units (12.8%) after a second injection. Overall success rate of reflux treatment with calcium hydroxylapatite was 71.8% in all ureteral units.
CONCLUSION: Endoscopic subureteral injection of calcium hydroxylapatite in children with primary low-grade VUR appears to be an effective, safe and minimally invasive technique.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17043923     DOI: 10.1007/s11255-006-9011-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  Evolution of the treatment of vesicoureteral reflux in Spain.

Authors:  Jose M Moran Penco; Andre Gomez Fraile; Jorge Rodríguez Alarcon; Francisco Garcia Merino; Diego Vela; Santiago Sanjuán Rodriguez; Aldolfo Aransay Brantot
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

2.  Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence.

Authors:  R Mayer; M Lightfoot; I Jung
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

Review 3.  Endoscopic management of vesicoureteral reflux: does it stand the test of time?

Authors:  Boris Chertin; Prem Puri
Journal:  Eur Urol       Date:  2002-12       Impact factor: 20.096

4.  Long-term results of the endoscopic correction of vesicoureteral reflux in children using autologous chondrocytes.

Authors:  A A Caldamone; D A Diamond
Journal:  J Urol       Date:  2001-06       Impact factor: 7.450

5.  Possible causes of unsuccessful endoscopic collagen treatment of vesicoureteric reflux in children.

Authors:  B Trsinar; D Cotic; C Oblak
Journal:  Eur Urol       Date:  1999-12       Impact factor: 20.096

6.  Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term follow-up.

Authors:  A Haferkamp; H Contractor; K Möhring; G Staehler; J Dörsam
Journal:  Urology       Date:  2000-05       Impact factor: 2.649

7.  Endoscopic subureteral collagen injection: are immunological concerns justified?

Authors:  M P Leonard; A Decter; K Hills; L W Mix
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

8.  Multicenter survey of endoscopic treatment of vesicoureteral reflux using polytetrafluoroethylene.

Authors:  P Puri; C Granata
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

Review 9.  Ten year experience with subureteric Teflon (polytetrafluoroethylene) injection (STING) in the treatment of vesico-ureteric reflux.

Authors:  P Puri
Journal:  Br J Urol       Date:  1995-02

10.  Outcome of endoscopic treatment for vesicoureteral reflux in children using polydimethylsiloxane.

Authors:  Adel A Al-Hunayan; Elijah O Kehinde; Mamdouh A Elsalam; Rola S Al-Mukhtar
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

View more
  4 in total

1.  Combination of calcium hydroxyapatite and autologous blood for endoscopic treatment of vesicoureteral reflux in children.

Authors:  Roozbeh Tanhaeivash; Abdol-Mohammad Kajbafzadeh; Atefeh Zeinoddini; Neda Khalili; Mona Vahidi Rad; Reza Heidari
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

2.  Large urethral prolapse formation after calcium hydroxylapatite (Coaptite) injection.

Authors:  H Henry Lai; Eric A Hurtado; Rodney A Appell
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-04-15

3.  Long-term results of endoscopic treatment of vesicoureteral reflux with the sub-ureteric injection of calcium hydroxyapatite.

Authors:  Tufan Tarcan; Ilker Tinay; Yusuf Temiz; Ferruh Simşek
Journal:  Int Urol Nephrol       Date:  2007-06-30       Impact factor: 2.370

4.  A comparison of calcium hydroxyapatite and dextranomer/hyaluronic Acid for the endoscopic treatment of vesicoureteral reflux.

Authors:  Tin C Ngo; Ilene Yi-Zhen Wong; William A Kennedy
Journal:  Adv Urol       Date:  2013-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.